Studies of bupropion's mechanism of antidepressant activity.

No abstract is available for this paper.

• Publication year

  1983

• Venue

  Journal of Clinical Psychiatry

• Publication date

  1983-05-01

• Fields of study

  Medicine, Psychology

• Identifiers
  PMID 6406468
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Mode of action of antidepressant drugs.

  1983cited by this paper
• The pharmacologic basis for therapeutic interest in bupropion.

  1983cited by this paper
• A structure-activity study of the transport sites for the hypothalamic and striatal catecholamine uptake systems. Similarities and differences.

  1982cited by this paper
• The effect of psychoactive drugs on beta-adrenergic receptor binding sites in rat brain.

  1980cited by this paper
• Behavioral and biochemical effects of the antidepressant bupropion (Wellbutrin): evidence for selective blockade of dopamine uptake in vivo.

  1980cited by this paper
• The involvement of dopamine in the central actions of bupropion, a new antidepressant [proceedings].

  1979cited by this paper
• Functional Aspects of the Norepinephrine Receptor Coupled Adenylate Cyclase System in the Limbic Forebrain and its Modification by Drugs which Precipitate or Alleviate Depression: Molecular Approaches to an Understanding of Affective Disorders

  1978cited by this paper
• Mode of action of antidepressant drugs.

  1978cited by this paper
• Effect of uptake inhibitors on the depletion of brain norepinephrine and serotonin after alpha-methyl-m-tyrosine administration to rats.

  1978cited by this paper
• Nomifensine and its derivatives as possible tools for studying amine uptake.

  1977cited by this paper
• Bupropion hydrochloride ((+/-) alpha-t-butylamino-3-chloropropiophenone HCl): a novel antidepressant agent.

  1977cited by this paper
• Action of various antidepressant treatments reduces reactivity of noradrenergic cyclic AMP-generating system in limbic forebrain

  1975cited by this paper
• A comparison of the capacities of isomers of amphetamine, deoxypipradrol and methylphenidate to inhibit the uptake of tritiated catecholamines into rat cerebral cortex slices, synaptosomal preparations of rat cerebral cortex, hypothalamus and striatum and into adrenergic nerves of rabbit aorta.

  1972cited by this paper
• Localization and persistence of metaraminol and -methyl-m-tyramine in rat and rabbit brain.

  1971cited by this paper
• Depletion of brain noradrenaline and dopamine by 6‐hydroxydopamine

  1971cited by this paper
• Catecholamine uptake by synaptosomes from rat brain. Structure-activity relationships of drugs with differential effects on dopamine and norepinephrine neurons.

  1971cited by this paper

• Different Effects of SSRIs, Bupropion, and Trazodone on Mitochondrial Functions and Monoamine Oxidase Isoform Activity

  2023cites this paper
• Use of Bupropion in the Management of Negative Symptom Schizophrenia: A Case Series

  2022cites this paper
• The Role of Bupropion in the Treatment of Women with Sexual Desire Disorder: A Systematic Review and Meta-Analysis

  2022cites this paper
• A 19-Year-Old Woman with a History of Depression and Fatal Cardiorespiratory Failure Following an Overdose of Prescribed Bupropion

  2021cites this paper
• Acute and chronic bupropion treatment does not prevent morphine-induced conditioned place preference in mice.

  2020cites this paper
• Cognition in mood disorders

  2020cites this paper
• Transport of Bupropion and its Metabolites by the Model CHO and HEK293 Cell Lines.

  2019cites this paper
• Phytotherapy of Male Hypoactive Sexual Desire of Psychogenic Origin: A Preliminary Study

  2018cites this paper
• A Dissociation of the Acute Effects of Bupropion on Positive Emotional Processing and Reward Processing in Healthy Volunteers

  2018cites this paper
• Why are Antidepressant Drugs Effective Smoking Cessation Aids?

  2017cites this paper
• Bupropion induces social anxiety in adolescent mice: Influence of housing conditions

  2017cites this paper
• Chiral Plasma Pharmacokinetics and Urinary Excretion of Bupropion and Metabolites in Healthy Volunteers

  2016cites this paper
• Acute movement disorders in the medical setting

  2016cites this paper
• Stereoselective Glucuronidation of Bupropion Metabolites In Vitro and In Vivo

  2016cites this paper
• Acute Dystonia After Single Dose of Bupropion

  2016cites this paper
• Neuropsychopharmacology of appetite in healthy volunteers

  2015cites this paper
• Bupropion Overdose Presenting as Status Epilepticus in an Infant.

  2015cites this paper
• Augmentation with antidepressants in schizophrenia treatment: benefit or risk

  2015cites this paper
• Effects of bupropion on the ejaculatory response of male rats

  2014cites this paper
• Bupropion precipitating acute psychosis: a case report.

  2014cites this paper
• Standard operational procedures for low sexual desire in men.

  2013cites this paper
• Acute behavioural effects of bupropion and naltrexone, alone and in combination, in non-deprived male rats presented with palatable mash

  2013cites this paper
• Structure and vibrational analysis of methyl 3-amino-2-butenoate.

  2013cites this paper
• Disorders of Male Sexual Desire

  2012cites this paper
• Sensitive, selective and rapid determination of bupropion and its major active metabolite, hydroxybupropion, in human plasma by LC-MS/MS: application to a bioequivalence study in healthy Indian subjects.

  2011cites this paper
• Pharmacotherapeutic management of nicotine dependence in pregnancy.

  2011cites this paper
• Indolizidine (-)-235B' and related structural analogs: discovery of nicotinic receptor antagonists that inhibit nicotine-evoked [3H]dopamine release.

  2011cites this paper
• Cytogenetic and Biochemical effects of Antidepression drug (wellbutrin) on Male Mice

  2010cites this paper
• Nicotine Addiction: Past and Present

  2010cites this paper
• The alpha2 adrenergic receptor antagonist idazoxan, but not the serotonin-2A receptor antagonist M100907, partially attenuated reward deficits associated with nicotine, but not amphetamine, withdrawal in rats.

  2010cites this paper
• Efectos del bupropión sobre depresión, ansiedad y abstinencia a nicotina

  2010cites this paper
• Neural substrates of psychostimulant withdrawal-induced anhedonia.

  2010cites this paper
• Nicotinic acetylcholine receptor efficacy and pharmacological properties of 3-(substituted phenyl)-2β-substituted tropanes.

  2010cites this paper
• Animal models and treatments for addiction and depression co-morbidity

  2009cites this paper
• Pharmacological and neurotoxicological actions mediated by bupropion and diethylpropion.

  2009cites this paper
• Resolution of Pregabalin and Mirtazapine Associated Restless Legs Syndrome by Bupropion in a Patient with Major Depressive Disorder

  2009cites this paper
• Influence of bupropion and calcium channel antagonists on the nicotine-induced memory-related response of mice in the elevated plus maze

  2009cites this paper
• Is the inhibition of nicotinic acetylcholine receptors by bupropion involved in its clinical actions?

  2009cites this paper
• Behavioural and pharmacological mechanisms of bupropion's anti-smoking effects: recent preclinical and clinical insights.

  2009cites this paper
• Nicotinic receptor-based therapeutics and candidates for smoking cessation.

  2009cites this paper
• PRECLINICAL STUDY: Pavlovian drug discrimination with bupropion as a feature positive occasion setter: substitution by methamphetamine and nicotine, but not cocaine

  2009cites this paper
• Cannabis reinforcement and dependence: role of the cannabinoid CB1 receptor

  2008cites this paper
• A Randomized, Double-Blind, Placebo-Controlled Study of the Effect of Sustained-Release Bupropion on Blood Pressure in Individuals With Mild Untreated Hypertension

  2008cites this paper
• Acute Psychosis After Bupropion Treatment in a Healthy 28-Year-Old Woman

  2008cites this paper
• PRECLINICAL STUDY: Effects of bupropion, alone or coadministered with nicotine, on social behavior in mice

  2008cites this paper
• Bupropion differentially alters the aversive, locomotor and rewarding properties of nicotine in CD-1 mice.

  2008cites this paper
• Bupropion Hydrochloride versus Placebo, in Combination with Cognitive Behavioral Therapy, for the Treatment of Cocaine Abuse/Dependence

  2008cites this paper
• Chronic bupropion differentially alters the reinforcing, reward-enhancing and conditioned motivational properties of nicotine in rats.

  2008cites this paper
• The effects of chronic versus acute desipramine on nicotine withdrawal and nicotine self-administration in the rat

  2008cites this paper
• Bupropion extended-release for depressive disorders

  2008cites this paper
• Predictors of smokeless tobacco abstinence.

  2008cites this paper
• Acute dystonia resulting from abrupt bupropion discontinuation.

  2007cites this paper
• Bupropion hydrochloride produces conditioned hyperactivity in rats.

  2007cites this paper
• Examining the clinical efficacy of bupropion and nortriptyline as smoking cessation agents in a rodent model of nicotine withdrawal

  2007cites this paper
• Cardiogenic shock and status epilepticus after massive bupropion overdose

  2007cites this paper
• Chronic bupropion attenuated the anhedonic component of nicotine withdrawal in rats via inhibition of dopamine reuptake in the nucleus accumbens shell

  2007influential citation
• Methamphetamine functions as a positive and negative drug feature in a Pavlovian appetitive discrimination task

  2007cites this paper
• Review of the pharmacology and clinical profile of bupropion, an antidepressant and tobacco use cessation agent.

  2006cites this paper
• Therapeutic challenges of attention-deficit hyperactivity disorder with substance use disorders

  2006cites this paper
• The promises and pitfalls of reboxetine.

  2006cites this paper
• Effects of co-administration of bupropion and nicotinic agonists on the elevated plus-maze test in mice.

  2006cites this paper
• 15 years of clinical experience with bupropion HCl: from bupropion to bupropion SR to bupropion XL.

  2005cites this paper
• Dopamine transporter availability in medication free and in bupropion treated depression: a 99mTc-TRODAT-1 SPECT study.

  2005cites this paper
• Bupropion XL in adults with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled study.

  2005cites this paper
• Role of dopamine in behavioral sensitization to ethanol in DBA/2J mice.

  2005cites this paper
• Naltrexone reduces the relative reinforcing value of nicotine in a cigarette smoking choice paradigm

  2005cites this paper
• Tolerance does not develop to the decrease in nicotine self-administration produced by repeated bupropion administration.

  2005cites this paper
• Effects of salbutamol upon performance on an operant screen for antidepressants

  2005cites this paper
• Pharmacogenetics.

  2004cites this paper
• Nicotine as a signal for the presence or absence of sucrose reward: a Pavlovian drug appetitive conditioning preparation in rats

  2004cites this paper
• Effects of acute administration of bupropion on behavior in the elevated plus-maze test by NMRI mice.

  2004cites this paper
• A Review of the Neuropharmacology of Bupropion, a Dual Norepinephrine and Dopamine Reuptake Inhibitor.

  2004cites this paper
• Neurochemical and Psychotropic Effects of Bupropion in Healthy Male Subjects

  2003cites this paper
• Bupropion and 4-OH-bupropion pharmacokinetics in relation to genetic polymorphisms in CYP2B6.

  2003cites this paper
• An open trial of bupropion for the treatment of adults with attention-deficit/hyperactivity disorder and bipolar disorder.

  2003cites this paper
• Effects of antidepressant drugs and GR 205171, an neurokinin-1 (NK1) receptor antagonist, on the response in the forced swim test and on monoamine extracellular levels in the frontal cortex of the mouse.

  2003cites this paper
• Hospital- and clinic-based smoking cessation interventions for smokers with cardiovascular disease.

  2003cites this paper
• Association of a Critical CSF Tryptophan Threshold Level with Depressive Relapse

  2003cites this paper
• Effect of bupropion on hippocampal neurotransmitters and on peripheral hormonal concentrations in the rat.

  2003cites this paper
• Investigating the actions of bupropion on dependence-related effects of nicotine in rats

  2003cites this paper
• Effect of bupropion on nicotine self-administration in rats

  2003influential citation
• Bupropion: pharmacological and clinical profile in smoking cessation.

  2003cites this paper
• Pharmacological Treatment of Substance Abuse Disorders

  2002cites this paper
• Influence of fluoxetine on the ability of bupropion to modulate extracellular dopamine and norepinephrine concentrations in three mesocorticolimbic areas of rats.

  2002cites this paper
• Reboxetine: attenuation of intravenous nicotine self-administration in rats.

  2002cites this paper
• Metabolism of Some “Second”– and “Fourth”–Generation Antidepressants: Iprindole, Viloxazine, Bupropion, Mianserin, Maprotiline, Trazodone, Nefazodone, and Venlafaxine

  1999cites this paper
• Comparison of the Effects of Antidepressants and Their Metabolites on Reuptake of Biogenic Amines and on Receptor Binding

  1999cites this paper
• Effect of bupropion on immunodensity of putative imidazoline receptors on platelets of depressed patients.

  1999cites this paper
• Plasma Agmatine and Platelet Imidazoline Receptors in Depression a

  1999cites this paper
• Bupropion slow-release response in depression: diagnosis and biochemistry.

  1998cites this paper
• Bupropion and sexual function: a placebo-controlled prospective study on diabetic men with erectile dysfunction.

  1997cites this paper
• Enantiomeric determination of the phenylmorpholinol metabolite of bupropion in human plasma using coupled achiral-chiral liquid chromatography.

  1997cites this paper
• Effects of the total extract and fractions of Hypericum perforatum in animal assays for antidepressant activity.

  1997cites this paper
• The effects of bupropion in vivo in the neostriatum of 5-day-old and adult rats.

  1997cites this paper
• Effects of the Total Extract and Fractions of Hypericum perforatum in Animal Assays for Antidepressant Activity

  1997cites this paper
• (2S,3S,5R)-2-(3,5-difluorophenyl)-3,5-dimethyl-2-morpholinol: a novel antidepressant agent and selective inhibitor of norepinephrine uptake.

  1996cites this paper
• Safety and Efficacy of Bupropion Combined With Bromocriptine for Treatment of Cocaine Dependence

  1996cites this paper
• Bupropion hydrochloride in attention deficit disorder with hyperactivity.

  1996cites this paper
• Paroxetine/bupropion combination treatment for refractory depression.

  1996cites this paper
• Bupropion induces sniffing: a possible dopaminergic mechanism.

  1996cites this paper